abnormal circulating chemokine level, abnormal conjunctival sac morphology, abnormal dendritic cell physiology, abnormal embryonic tissue morphology, abnormal enterocyte proliferation, abnormal eyelid margin morphology, abnormal fetal cardiomyocyte proliferation, abnormal hair follicle development, abnormal hair follicle morphology, abnormal hair follicle orientation, abnormal long bone epiphyseal plate proliferative zone, abnormal long bone hypertrophic chondrocyte zone, abnormal lung development, abnormal lung epithelium morphology, abnormal lung saccule morphology, abnormal lung vasculature morphology, abnormal macrophage physiology, abnormal mammary gland duct morphology, abnormal mitral valve morphology, abnormal myocardium layer morphology, abnormal respiratory conducting tube morphology, abnormal semilunar valve morphology, abnormal skin condition, abnormal trabecula carnea morphology, abnormal trophoblast layer morphology, abnormal vibrissa morphology, absent Descemet membrane, absent Meibomian glands, absent Schlemm's canal, absent corneal endothelium, aphakia, curly vibrissae, decreased body length, decreased body size, decreased bone mass, decreased cardiac muscle contractility, decreased cell proliferation, decreased circulating tumor necrosis factor level, decreased fetal weight, decreased hematocrit, decreased physiological sensitivity to xenobiotic, decreased spongiotrophoblast size, decreased survivor rate, decreased susceptibility to endotoxin shock, decreased trabecular bone thickness, decreased transforming growth factor beta level, dermatitis, digestive/alimentary phenotype, dilated respiratory conducting tube, distorted hair follicle pattern, early eyelid opening, enhanced leukocyte tethering or rolling, enlarged aortic valve, enlarged esophagus, enlarged myocardial fiber, enlarged pulmonary valve, eye opacity, eyelids open at birth, failure of eyelid fusion, impaired skin barrier function, increased T-helper 1 cell number, increased T-helper 17 cell number, increased T-helper 2 cell number, increased bone marrow cell number, increased bone mineral content, increased circulating interleukin-17 level, increased erythrocyte cell number, increased heart left ventricle size, increased heart ventricle size, increased heart weight, increased incidence of corneal inflammation, increased interleukin-10 secretion, increased interleukin-17 secretion, increased left ventricle weight, increased macrophage cell number, increased neutrophil cell number, increased pruritus, increased sensitivity to induced morbidity/mortality, increased spleen red pulp amount, increased susceptibility to induced colitis, increased susceptibility to weight loss, increased width of hypertrophic chondrocyte zone, lethality throughout fetal growth and development, incomplete penetrance, lethality, incomplete penetrance, myeloid hyperplasia, neonatal lethality, complete penetrance, neonatal lethality, incomplete penetrance, no abnormal phenotype detected, pale lung, pathological neovascularization, perinatal lethality, complete penetrance, perinatal lethality, incomplete penetrance, postnatal lethality, complete penetrance, postnatal lethality, incomplete penetrance, premature death, reduced male fertility, respiratory system phenotype, short vibrissae, thick aortic valve, thick aortic valve cusps, thick lung-associated mesenchyme, thick pulmonary valve, thick pulmonary valve cusps, thick tricuspid valve cusps, thick ventricular wall, thin myocardium, vacuolated lens